GlassScriptPhysician profile
Stephanie D Davis
NPI 1790114189
$1,682.39
in general payments reported to CMS, 2019-2025
22 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $146 · 2023: $585 · 2024: $408 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $387.93 | 2023-2025 | |
| Astellas Pharma US INC | $291.03 | 2023-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $178.74 | 2022-2023 | Ova1 |
| Abbvie INC. | $141.69 | 2021-2024 | |
| Organon LLC | $112.40 | 2023-2025 | Nexplanon, Jada System |
| Pfizer INC. | $83.45 | 2023-2025 | |
| Shield Therapeutics INC | $73.59 | 2024 | |
| Hologic Sales and Service, LLC | $70.14 | 2022-2025 | Aptima, Novasure, Acessa Provu System |
| Biogen, INC. | $59.37 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $39.36 | 2023-2024 | Slynd |
| Avion Pharmaceuticals | $39.24 | 2021-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $32.20 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $31.93 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $20.96 | 2023 | Gardasil 9 |
| Boston Scientific Corporation | $18.79 | 2023 | Ingevity Mri |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Exact Sciences Corporation | $15.67 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $15.57 | 2023 | Twirla |
| Therapeuticsmd, INC. | $15.36 | 2022 | |
| Radius Health, INC. | $13.46 | 2024 | Tymlos |
| Sage Therapeutics, LLC | $13.28 | 2021 | |
| Evofem Biosciences, INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.